tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AMGN Stock Latest News

AMGN Earnings this Week: How Will it Perform?
Pre-EarningsAMGN Earnings this Week: How Will it Perform?
12h ago
AMGN
Amgen’s Promising Phase 3 Study on Blinatumomab for Leukemia: What Investors Need to Know
PremiumCompany Announcements
Amgen’s Promising Phase 3 Study on Blinatumomab for Leukemia: What Investors Need to Know
6d ago
AMGN
Amgen’s Avacopan Study: A Closer Look at Long-term Safety in ANCA-associated Vasculitis
PremiumCompany Announcements
Amgen’s Avacopan Study: A Closer Look at Long-term Safety in ANCA-associated Vasculitis
6d ago
AMGN
Amgen’s Tarlatamab Study: A Potential Game-Changer in Lung Cancer Treatment
PremiumCompany Announcements
Amgen’s Tarlatamab Study: A Potential Game-Changer in Lung Cancer Treatment
6d ago
ONC
AMGN
Amgen’s ABP 234 vs. Keytruda: A New Hope for Lung Cancer Treatment?
PremiumCompany Announcements
Amgen’s ABP 234 vs. Keytruda: A New Hope for Lung Cancer Treatment?
6d ago
AMGN
Amgen’s CodeBreaK 202: A New Frontier in Lung Cancer Treatment
PremiumCompany AnnouncementsAmgen’s CodeBreaK 202: A New Frontier in Lung Cancer Treatment
6d ago
AMGN
Amgen’s Apremilast Study: A Potential Game-Changer for Pediatric Behçet’s Disease
Premium
Company Announcements
Amgen’s Apremilast Study: A Potential Game-Changer for Pediatric Behçet’s Disease
6d ago
AMGN
Amgen’s Innovative Study on AMG 193: A Potential Game-Changer in Cancer Treatment
Premium
Company Announcements
Amgen’s Innovative Study on AMG 193: A Potential Game-Changer in Cancer Treatment
6d ago
AMGN
Amgen’s Phase 2a Study on Autoimmune Diseases: A Potential Game-Changer?
PremiumCompany Announcements
Amgen’s Phase 2a Study on Autoimmune Diseases: A Potential Game-Changer?
6d ago
AMGN
Amgen’s Maridebart Cafraglutide Study: A Potential Game-Changer in Heart Failure Treatment
PremiumCompany Announcements
Amgen’s Maridebart Cafraglutide Study: A Potential Game-Changer in Heart Failure Treatment
6d ago
AMGN
Amgen’s Olpasiran Study: A Potential Game-Changer in Cardiovascular Treatment
PremiumCompany Announcements
Amgen’s Olpasiran Study: A Potential Game-Changer in Cardiovascular Treatment
6d ago
AMGN
Amgen’s AMG 509 Study: A Potential Game-Changer in Prostate Cancer Treatment
PremiumCompany Announcements
Amgen’s AMG 509 Study: A Potential Game-Changer in Prostate Cancer Treatment
6d ago
ONC
AMGN
Amgen’s Tarlatamab Study: A Potential Game-Changer in Lung Cancer Treatment
PremiumCompany AnnouncementsAmgen’s Tarlatamab Study: A Potential Game-Changer in Lung Cancer Treatment
6d ago
AMGN
Amgen’s Long-term Study on Dazodalibep: A Potential Breakthrough for Sjögren’s Syndrome
Premium
Company Announcements
Amgen’s Long-term Study on Dazodalibep: A Potential Breakthrough for Sjögren’s Syndrome
6d ago
AMGN
Amgen’s Latest Clinical Study Update: A New Hope for Small Cell Lung Cancer?
Premium
Company Announcements
Amgen’s Latest Clinical Study Update: A New Hope for Small Cell Lung Cancer?
6d ago
AMGN
Amgen’s Apremilast Study: A New Hope for Pediatric Patients
PremiumCompany Announcements
Amgen’s Apremilast Study: A New Hope for Pediatric Patients
6d ago
AMGN
Amgen’s New Prostate Cancer Study: A Potential Game-Changer?
PremiumCompany Announcements
Amgen’s New Prostate Cancer Study: A Potential Game-Changer?
6d ago
AMGN
Amgen’s Romiplostim Study: A Potential Game-Changer for Cancer Treatment
PremiumCompany Announcements
Amgen’s Romiplostim Study: A Potential Game-Changer for Cancer Treatment
6d ago
AMGN
Amgen’s Phase 3 Study on Xaluritamig: A Potential Game-Changer in Prostate Cancer Treatment
PremiumCompany Announcements
Amgen’s Phase 3 Study on Xaluritamig: A Potential Game-Changer in Prostate Cancer Treatment
6d ago
AMGN
Amgen’s Phase 3 Study on Etelcalcetide: A Potential Game-Changer for Pediatric SHPT Treatment
PremiumCompany AnnouncementsAmgen’s Phase 3 Study on Etelcalcetide: A Potential Game-Changer for Pediatric SHPT Treatment
6d ago
AMGN
Amgen’s AMG 410 Study: A Potential Game-Changer in KRAS-Altered Tumor Treatment
Premium
Company Announcements
Amgen’s AMG 410 Study: A Potential Game-Changer in KRAS-Altered Tumor Treatment
6d ago
AMGN
Amgen’s Pediatric Psoriatic Arthritis Study: A Potential Game-Changer?
Premium
Company Announcements
Amgen’s Pediatric Psoriatic Arthritis Study: A Potential Game-Changer?
6d ago
AMGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >